Literature DB >> 25040075

The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata.

Taisuke Ito1, Yoshiki Tokura.   

Abstract

The aetiology of alopecia areata (AA) is still not fully understood. However, recent clinical and experimental studies have provided insights into the pathomechanisms of AA and revealed that it is an organ-specific and cell-mediated autoimmune disease. Some triggers, such as viral infections, trauma, hormones and emotional/physical stressors, may cause activation of autoreactive T cells that target hair follicle (HF) autoantigens. In these immunological responses, cytokines and chemokines are regarded as key players that mediate the autoimmune inflammation. This results in the collapse of HF immune privilege, which is central to the pathogenesis of AA. This essay will focus on how cytokines and chemokines contribute to the immunological aspects of AA. The management of AA often remains difficult in a number of cases. Our review suggests that novel therapies for AA may involve targeting cytokines and chemokines.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alopecia areata; chemokine; cytokine; immune privilege; swarm of bees

Mesh:

Substances:

Year:  2014        PMID: 25040075     DOI: 10.1111/exd.12489

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  23 in total

1.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Understanding autoimmunity of vitiligo and alopecia areata.

Authors:  Jillian F Rork; Mehdi Rashighi; John E Harris
Journal:  Curr Opin Pediatr       Date:  2016-08       Impact factor: 2.856

Review 3.  Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.

Authors:  Amos Gilhar; Adam G Schrum; Amos Etzioni; Herman Waldmann; Ralf Paus
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

4.  Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata.

Authors:  Sumeyya Deniz Celik; Omer Ates
Journal:  J Clin Lab Anal       Date:  2018-01-18       Impact factor: 2.352

Review 5.  The influence of interferon on healthy and diseased skin.

Authors:  Grace A Hile; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  Cytokine       Date:  2018-12-06       Impact factor: 3.861

6.  Serum Levels of Interleukin-2 in Patients with Alopecia Areata: Relationship with Clinical Type and Duration of the Disease.

Authors:  Emina Kasumagić-Halilovic; Semra Cavaljuga; Nermina Ovcina-Kurtovic; Lamija Zecevic
Journal:  Skin Appendage Disord       Date:  2018-02-06

Review 7.  New and Emerging Therapies for Alopecia Areata.

Authors:  Aunna Pourang; Natasha Atanaskova Mesinkovska
Journal:  Drugs       Date:  2020-05       Impact factor: 9.546

8.  SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.

Authors:  Zhen Gao; Yu-Qing Jin; Wei Wu
Journal:  Oncotarget       Date:  2017-05-16

9.  Can the Cytokine Analysis of the Scales on Alopecic Patch Predict the Response to Diphenylcyclopropenone Treatment in Alopecia Areata Patients?

Authors:  Si Hyub Lee; Jong Hyuk Moon; Dae Hyun Ban; Ji Won Byun; Jeonghyun Shin; Gwang Seong Choi
Journal:  Ann Dermatol       Date:  2018-02-21       Impact factor: 1.444

Review 10.  Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options.

Authors:  Evan Darwin; Penelope A Hirt; Raymond Fertig; Brett Doliner; Gina Delcanto; Joaquin J Jimenez
Journal:  Int J Trichology       Date:  2018 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.